Prelude Capital Management’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,197
| Closed | -$18.2K | – | 1386 |
|
|
2025
Q1 | $18.2K | Sell |
10,197
-2,700
| -21% | -$4.81K | ﹤0.01% | 1042 |
|
|
2024
Q4 | $40.7K | Sell |
12,897
-4,900
| -28% | -$15.5K | ﹤0.01% | 1025 |
|
|
2024
Q3 | $36.7K | Sell |
17,797
-18,400
| -51% | -$37.9K | ﹤0.01% | 1119 |
|
|
2024
Q2 | $52.8K | Sell |
36,197
-400
| -1% | -$584 | ﹤0.01% | 1049 |
|
|
2024
Q1 | $85.6K | Buy |
36,597
+10,200
| +39% | +$23.9K | ﹤0.01% | 1103 |
|
|
2023
Q4 | $53.3K | Buy |
26,397
+4,500
| +21% | +$9.09K | ﹤0.01% | 941 |
|
|
2023
Q3 | $106K | Buy |
21,897
+10,823
| +98% | +$52.4K | 0.01% | 845 |
|
|
2023
Q2 | $75.7K | Buy |
+11,074
| New | +$75.7K | ﹤0.01% | 836 |
|